Literature DB >> 18418716

Mouse monoclonal antibodies in biological research: strategies for high-throughput production.

Pieranna Chiarella1, Vito Michele Fazio.   

Abstract

Mouse monoclonal antibodies have become key components in basic research as well as in the clinical laboratory. Being invaluable tools in many biological assays, they continue to be the primary choice in the research field, although the conventional technology used for hybridoma generation and screening is a still lengthy, time-consuming and low-throughput process. With the advent of genetic immunisation and the application of automation and microarray to the traditional biological assays, the monoclonal antibody field has been revolutionised. Here, we will briefly review the most relevant strategies which have made the manufacture of murine monoclonal antibodies a faster and high-throughput technology.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18418716     DOI: 10.1007/s10529-008-9706-5

Source DB:  PubMed          Journal:  Biotechnol Lett        ISSN: 0141-5492            Impact factor:   2.461


  14 in total

1.  A high-affinity human/mouse cross-reactive monoclonal antibody, specific for VEGFR-2 linear and conformational epitopes.

Authors:  Jianfei Huang; Yang Tan; Qi Tang; Xinjian Liu; Xiaohong Guan; Zhenqing Feng; Jin Zhu
Journal:  Cytotechnology       Date:  2010-04-13       Impact factor: 2.058

2.  High-affinity monoclonal antibodies to cell surface tumor antigen glypican-3 generated through a combination of peptide immunization and flow cytometry screening.

Authors:  Yen Phung; Wei Gao; Yan-Gao Man; Satoshi Nagata; Mitchell Ho
Journal:  MAbs       Date:  2012-07-23       Impact factor: 5.857

3.  Multiplexed evaluation of capture agent binding kinetics using arrays of silicon photonic microring resonators.

Authors:  Ji-Yeon Byeon; Ryan C Bailey
Journal:  Analyst       Date:  2010-11-18       Impact factor: 4.616

4.  Antibody-like Biorecognition Sites for Proteins from Surface Imprinting on Nanoparticles.

Authors:  Snehasis Bhakta; Mohammad Saiful Islam Seraji; Steven L Suib; James F Rusling
Journal:  ACS Appl Mater Interfaces       Date:  2015-12-17       Impact factor: 9.229

Review 5.  Axon repair: surgical application at a subcellular scale.

Authors:  Wesley C Chang; Elizabeth Hawkes; Christopher G Keller; David W Sretavan
Journal:  Wiley Interdiscip Rev Nanomed Nanobiotechnol       Date:  2010 Mar-Apr

6.  Generation of antibody-producing hybridomas following one single immunization with a targeted DNA vaccine.

Authors:  I Øynebråten; T-O Løvås; K Thompson; B Bogen
Journal:  Scand J Immunol       Date:  2012-04       Impact factor: 3.487

7.  Antibody discovery ex vivo accelerated by the LacO/LacI regulatory network.

Authors:  Munehisa Yabuki; W Jason Cummings; John B Leppard; Robert M Immormino; Christi L Wood; Daniel S Allison; Patrick W Gray; Larry W Tjoelker; Nancy Maizels
Journal:  PLoS One       Date:  2012-04-27       Impact factor: 3.240

8.  Ribosome display selection of a murine IgG₁ Fab binding affibody molecule allowing species selective recovery of monoclonal antibodies.

Authors:  Sebastian Grimm; Feifan Yu; Per-Åke Nygren
Journal:  Mol Biotechnol       Date:  2011-07       Impact factor: 2.695

Review 9.  Monoclonal Antibody Combinations that Present Synergistic Neutralizing Activity: A Platform for Next-Generation Anti-Toxin Drugs.

Authors:  Eran Diamant; Amram Torgeman; Eyal Ozeri; Ran Zichel
Journal:  Toxins (Basel)       Date:  2015-05-29       Impact factor: 4.546

10.  Evaluating the synergistic neutralizing effect of anti-botulinum oligoclonal antibody preparations.

Authors:  Eran Diamant; Bat-El Lachmi; Adi Keren; Ada Barnea; Hadar Marcus; Shoshana Cohen; Alon Ben David; Ran Zichel
Journal:  PLoS One       Date:  2014-01-27       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.